Understanding the causes and prevention of polydrug overdoses in North Carolina
RFA-CE-22-011: Risk and Protective factors of Polydrug Overdose in North Carolina
This study is looking into the growing problem of polydrug overdoses in North Carolina to understand what causes them, so we can find better ways to prevent these dangerous situations and save lives.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10839276 on NIH RePORTER |
What this research studies
This research investigates the rising issue of polydrug overdoses in North Carolina, particularly focusing on the factors that contribute to these incidents. By analyzing data from healthcare, insurance, and correctional systems, the study aims to identify risk and protective factors associated with polydrug use and overdose. The research will involve collaboration with various systems to gather linked data, which will help establish benchmarks for polydrug overdose incidence and inform prevention strategies. The ultimate goal is to reduce the number of overdose deaths through targeted interventions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals in North Carolina who have experienced or are at risk for polydrug overdoses, particularly those with recent contact with healthcare or correctional systems.
Not a fit: Patients who do not reside in North Carolina or who have not been involved with healthcare or correctional systems may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved prevention strategies and reduced overdose deaths among individuals at risk.
How similar studies have performed: Other research has shown success in identifying risk factors for drug overdoses, but this specific focus on polydrug overdoses in North Carolina is relatively novel.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Ranapurwala, Shabbar I — Univ of North Carolina Chapel Hill
- Study coordinator: Ranapurwala, Shabbar I
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.